Correlation Between Verrica Pharmaceuticals and Intracellular
Can any of the company-specific risk be diversified away by investing in both Verrica Pharmaceuticals and Intracellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verrica Pharmaceuticals and Intracellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verrica Pharmaceuticals and Intracellular Th, you can compare the effects of market volatilities on Verrica Pharmaceuticals and Intracellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verrica Pharmaceuticals with a short position of Intracellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verrica Pharmaceuticals and Intracellular.
Diversification Opportunities for Verrica Pharmaceuticals and Intracellular
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Verrica and Intracellular is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and Intracellular Th in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intracellular Th and Verrica Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verrica Pharmaceuticals are associated (or correlated) with Intracellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intracellular Th has no effect on the direction of Verrica Pharmaceuticals i.e., Verrica Pharmaceuticals and Intracellular go up and down completely randomly.
Pair Corralation between Verrica Pharmaceuticals and Intracellular
Given the investment horizon of 90 days Verrica Pharmaceuticals is expected to under-perform the Intracellular. But the stock apears to be less risky and, when comparing its historical volatility, Verrica Pharmaceuticals is 1.89 times less risky than Intracellular. The stock trades about -0.01 of its potential returns per unit of risk. The Intracellular Th is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 8,352 in Intracellular Th on November 1, 2024 and sell it today you would earn a total of 4,348 from holding Intracellular Th or generate 52.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verrica Pharmaceuticals vs. Intracellular Th
Performance |
| Timeline |
| Verrica Pharmaceuticals |
| Intracellular Th |
Verrica Pharmaceuticals and Intracellular Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verrica Pharmaceuticals and Intracellular
The main advantage of trading using opposite Verrica Pharmaceuticals and Intracellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verrica Pharmaceuticals position performs unexpectedly, Intracellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intracellular will offset losses from the drop in Intracellular's long position.| Verrica Pharmaceuticals vs. Inventiva Sa | Verrica Pharmaceuticals vs. Edgewise Therapeutics | Verrica Pharmaceuticals vs. Vigil Neuroscience | Verrica Pharmaceuticals vs. Connect Biopharma Holdings |
| Intracellular vs. Alkermes Plc | Intracellular vs. Ironwood Pharmaceuticals | Intracellular vs. Pacira BioSciences, | Intracellular vs. Collegium Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |